Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Journey Medical (DERM) Beginning Cash Balance: 2020-2024

Historic Beginning Cash Balance for Journey Medical (DERM) over the last 5 years, with Dec 2024 value amounting to $27.4 million.

  • Journey Medical's Beginning Cash Balance fell 15.27% to $20.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $22.5 million, marking a year-over-year decrease of 9.39%. This contributed to the annual value of $27.4 million for FY2024, which is 14.26% down from last year.
  • Per Journey Medical's latest filing, its Beginning Cash Balance stood at $27.4 million for FY2024, which was down 14.26% from $32.0 million recorded in FY2023.
  • In the past 5 years, Journey Medical's Beginning Cash Balance registered a high of $49.1 million during FY2022, and its lowest value of $4.8 million during FY2020.
  • In the last 3 years, Journey Medical's Beginning Cash Balance had a median value of $32.0 million in 2023 and averaged $36.2 million.
  • As far as peak fluctuations go, Journey Medical's Beginning Cash Balance skyrocketed by 493.84% in 2022, and later crashed by 34.80% in 2023.
  • MRY analysis of 5 years shows Journey Medical's Beginning Cash Balance stood at $4.8 million in 2020, then surged by 72.15% to $8.3 million in 2021, then surged by 493.84% to $49.1 million in 2022, then plummeted by 34.80% to $32.0 million in 2023, then fell by 14.26% to $27.4 million in 2024.
  • Its last three reported values are $27.4 million in FY2024, $32.0 million for FY2023, and $49.1 million during FY2022.